Roche making Sparks

Roche have, today, announced plans to enter a merger agreement to acquire Spark Therapeutics.

Spark Therapeutics are a leader in discovering, developing and delivering gene therapies – they are the only biotech company that has successfully commercialised a gene therapy for a genetic disease in the US.

Though this is not directly linked to treatment advancements for people with type 1 diabetes, this move could one day benefit people like my son who have type 1.

For more detailed information on the merger agreement please see the below link:
Roche merger agreement to acquire Spark Therapeutics

Leave a Reply

Your email address will not be published. Required fields are marked *

Proudly powered by WordPress | Theme: Baskerville 2 by Anders Noren.

Up ↑